A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with Tourette syndrome will be conducted by Wesley Medical Research, with the cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney.

The trial is the first of its kind in Australia and will take place at Wesley Medical Research in Brisbane led by Chief Investigator and neuropsychiatrist Dr Philip Mosley.

Participants will complete two periods of treatment with either a medicinal cannabis drug or a placebo, with both investigators and participants unaware of treatment status until the end of the trial.

Click here to read the complete article

University of Sydney

Recent News Articles

Friday April 26

Lawmakers Want Legal Protections For Universities That Research Marijuana - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

A bipartisan group of lawmakers on Capitol Hill is asking House leadership to protect universities…

1787 hits

Friday April 26

Hemp cultivation wins approval in Connecticut Senate - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Connecticut farmers are one step closer to joining the burgeoning hemp industry after the Senate…

2477 hits

Friday April 26

Jobs in pot are at an all-time high, but the boom is causing rifts in…

in Finance

by Bruce Kennedy - Editor in Chief

Jobs in pot might be at an all-time high, according to a new report.

2160 hits

Friday April 26

How Marijuana Works To Help Those With Multiple Sclerosis - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

In double-blind, placebo controlled trials, MS patients who use cannabis oil, synthetic THC, or an…

2240 hits

Monday April 29

Maine’s marijuana dilemma: ‘Cannabiz’ poised to grow, but in a holding pattern - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

Maine has no legal market for recreational cannabis, more than two years after it became…

900 hits